cholera

Genome sequences from isolates of Vibrio cholerae collected before and after the so-called seventh cholera pandemicprovide insights into the strain's evolution.

The Malaysian company received CE-IVD marking for its PCR-based tests for influenza A/B and for cholera. 

Researchers are looking through well-preserved remains of cholera victims in an abandoned Italian cemetery for Vibrio cholerae DNA.

Several regulatory genes are responsible for starting a process that both kills surrounding bacteria and adds their DNA to the pathogen's own genome.

NEW YORK (GenomeWeb) – A team from Japan and the US used a combination of whole-genome sequencing, exome sequencing, and "oncovirome" sequencing to scrutinize matched tumor and normal samples from more than 500 individuals from different populations who had a form of liver cancer called hepatocel

NEW YORK (GenomeWeb News) – In Cell, researchers from China and the US described an approach for analyzing the genomes of individual human oocytes — a strategy that's expected to prove useful for understandi

NEW YORK (GenomeWeb News) - In Lancet Respiratory Medicine, an international team led by investigators at the Duke University Medical Center described findings from a prospective study looking at asthma-related information that can be

NEW YORK (GenomeWeb News) – The cholera strain behind the outbreak that emerged in Haiti in 2010 has a limited ability to acquire new genes, according to an evolutionary analysis of isolate genomes conducted by Cheryl Tarr at

NEW YORK (GenomeWeb News) – Two research consortia will receive as much as $52.4 million from the National Institute of Allergy and Infectious Diseases to continue studies using structural genomics to characterize the structures of proteins from a number of dangerous bacterial, protozoan, and vir

The study's main conclusion — that the Haitian cholera strain probably originated from South Asia, rather than Latin America, and was introduced by human activity — had already been demonstrated earlier by a team from the US Centers for Disease Control and Prevention, which used DNA fingerprinting technology, but it is disputed by some experts.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.